The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.
- 1 June 1987
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 84 (11) , 3733-3737
- https://doi.org/10.1073/pnas.84.11.3733
Abstract
A papetide secreted by some tumor cells in vitro imparts anchorage-independent growth to normal rat kidney (NRK) cells and has been termed transforming growth factor type .alpha. (TGF-.alpha.). To directly investigate the transforming properties of this factor, the human sequence coding for TGF-.alpha. was placed under the control of either a metallothionein promoter or a retroviral long terminal repeat. These constructs failed to induce morphological transformation upon transfection of NIH 3T3 cells, whereas viral oncogenes encoding a truncated form of its cognate receptor, the EGF receptor, or another growth factor, sis/platelet-derived growth factor 2, efficiently induced transformed foci. When NIH 3T3 clonal sublines were selected by transfection of TGF-.alpha. expression vectors in the presence of a dominant selectable marker, they were shown to secrete large amounts of TGF-.alpha. into the medium, to have downregulated EGF receptors, and to be inhibited in growth by TGF-.alpha. monoclonal antibody. These results indicated that secreted TGF-.alpha. interacts with its receptor at a cell surface location. Single cell-derived TGF-.alpha.-expressing sublines grew to high saturation density in culture. However, when plated as single cells on contact-inhibited monolayers of NIH 3T3 cells, they failed to form colonies, whereas v-sis- and v-erbB-transfected cells formed transformed colonies under the same conditions. Moreover, TGF-.alpha.-expressing sublines were not tumorigenic in nude mice. These and other results imply that TGF-.alpha. exerts a growth-promoting effect on the entire NIH 3T3 cell population after secretion into the medium but little, if any, effect on the individual cell synthesizing this factor. It is concluded that the normal coding sequence for TGF-.alpha. is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.This publication has 33 references indexed in Scilit:
- Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformationCell, 1986
- Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicityCell, 1985
- Evidence That the v- sis Gene Product Transforms by Interaction with the Receptor for Platelet-Derived Growth FactorScience, 1985
- Cloning and sequence analysis of a cDNA for rat transforming growth factor-αNature, 1985
- Cell, 1984
- Construction and applications of a highly transmissible murine retrovirus shuttle vectorCell, 1984
- Human transforming growth factor-α: Precursor structure and expression in E. coliPublished by Elsevier ,1984
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980
- Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cellsNature, 1976
- Human sarcoma cells in culture: Identification by colony-forming ability on monolayers of normal cellsExperimental Cell Research, 1970